Basic information Supplier
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Structure

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl

Chemical Properties

Boiling point 945.8±65.0 °C(Predicted)
Density  1.75±0.1 g/cm3(Predicted)
pka 2.76±0.70(Predicted)
FDA UNII TD2G64J9XN

Preparation Products And Raw materials

β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Suppliers